CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 95 enrolled
Drug / intervention
Farlong NotoGinseng™ (Farlong Ginseng Plus® Panax Notoginseng extract) +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04069715
NCT04069715Phase 2Completed
CompareCT.gov

A Randomized, Placebo-controlled, Double-blind, Parallel Study to Determine the Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plus®) on Cholesterol and Blood Pressure

LongStar HealthPro, Inc. DBA Farlong Pharmaceutical·interventional·Posted Aug 28, 2019·Updated May 17, 2021

In Brief

A Phase 2 clinical trial evaluating Farlong NotoGinseng™ (Farlong Ginseng Plus® Panax Notoginseng extract) and Placebo for Hyperlipidemias and Hypertension. Completed, enrolled 95 participants.

Detailed Summary

In this randomized, placebo-controlled, double-blind parallel study in human participants with elevated LDL-C and elevated BP described here, the clinical benefits of Farlong NotoGinseng™ (Farlong Ginseng Plus® Panax Notoginseng extract), a product made of highly concentrated pharmaceutical grade notoginseng root extract, and containing high potency bioactive components, notoginsenoside, ginsenoside Rb1 and ginsenoside Rg1, will be investigated for its efficacy on LDL-C and blood pressure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperlipidemias, Hypertension
Countries--
CollaboratorsYunnan Panlong Yunhai Pharmaceutical Group Co., Ltd., KGK Science Inc.

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedAug 28, 2019
Enrollment StartJul 20, 2016
Primary CompletionJun 1, 2019
TodayJul 1, 2026
Enrollment to primary: 2.9 yearsPosted 6.8 years ago

Interventions

Farlong NotoGinseng™ (Farlong Ginseng Plus® Panax Notoginseng extract)dietary

A product made of highly concentrated pharmaceutical grade notoginseng root extract, and containing high potency bioactive components, notoginsenoside, ginsenoside Rb1, Rg1, Rd, Re and Rb2.

Placeboother

Turmeric 0.4%, Rice Flour 76.6%, Magnesium stearate 23%, capsule shell (gelatin) 61 mg